Showing results (161-170 of 201) with videos related to
Sort By:
Pageof 21
Surgery Today|November 8, 2017
Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinomaHideaki Takeyama, Toru Beppu, Takaaki Higashi, et al.Journal of Gastroenterology|July 16, 2026
Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nationwide clinical databaseDaisuke Hashimoto, Shinya Hirakawa, Masamichi Mizuma, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 22, 2016
Preoperative platelet-to-lymphocyte ratio can predict recurrence beyond the Milan criteria after hepatectomy for patients with hepatocellular carcinomaTakayoshi Kaida, Hidetoshi Nitta, Yuki Kitano, et al.Surgical Oncology|November 9, 2017
The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasmsKosuke Mima, Shuji Ogino, Shigeki Nakagawa, et al.Oncotarget|May 15, 2018
Prognostic value of LINE-1 methylation level in 321 patients with primary liver cancer including hepatocellular carcinoma and intrahepatic cholangiocarcinomaTatsunori Miyata, Yo-Ichi Yamashita, Yoshifumi Baba, et al.Anticancer Research|December 27, 2017
Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic DisseminationKunitaka Kuramoto, Toru Beppu, Hidetoshi Nitta, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 16, 2018
Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinomaShigeki Nakagawa, Hirohisa Okabe, Mayuko Ouchi, et al.Scientific Reports|November 16, 2016
Novel method to rescue a lethal phenotype through integration of target gene onto the X-chromosomeKazuya Sakata, Kimi Araki, Hiroyasu Nakano, et al.Journal of Gastroenterology|June 17, 2023
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas SocietyYoshito Tomimaru, Hidetoshi Eguchi, Yoshimitsu Shimomura, et al.Trials|February 6, 2022
Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study)Tomohisa Yamamoto, Tsutomu Fujii, Satoshi Hirano, et al.Pageof 21